| Product NDC: | 17714-133 |
| Proprietary Name: | ACETAMINOPHEN PM |
| Non Proprietary Name: | ACETAMINOPHEN PM |
| Active Ingredient(s): | 500; 25 mg/1; mg/1 & nbsp; ACETAMINOPHEN PM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 17714-133 |
| Labeler Name: | Advance Pharmaceutical Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20020109 |
| Package NDC: | 17714-133-50 |
| Package Description: | 50 TABLET in 1 BOTTLE (17714-133-50) |
| NDC Code | 17714-133-50 |
| Proprietary Name | ACETAMINOPHEN PM |
| Package Description | 50 TABLET in 1 BOTTLE (17714-133-50) |
| Product NDC | 17714-133 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | ACETAMINOPHEN PM |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20020109 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Advance Pharmaceutical Inc. |
| Substance Name | ACETAMINOPHEN; DIPHENHYDRAMINE HYDROCHLORIDE |
| Strength Number | 500; 25 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |